Lanvin Group Holdings Limited (LANV)
Market Cap | 232.03M |
Revenue (ttm) | 478.19M |
Net Income (ttm) | -245.92M |
Shares Out | 145.02M |
EPS (ttm) | -2.62 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 520 |
Open | 1.550 |
Previous Close | 1.590 |
Day's Range | 1.550 - 1.600 |
52-Week Range | 1.270 - 6.000 |
Beta | 0.04 |
Analysts | Hold |
Price Target | 5.00 (+212.5%) |
Earnings Date | Apr 30, 2024 |
About LANV
Lanvin Group Holdings Limited operates as a couture house worldwide. The company offers ready-to-wear, made to measure, footwear, leather goods, costume jewelry, accessories, eyewear, and childrenswear under the Lanvin brand name; ready-to-wear, legwear, lingerie and beachwear, and accessories under the Wolford brand; footwear under the Sergio Rossi brand name; luxury womenswear, footwear, handbags, jewelry, and leather goods under the St. John brand; and leisurewear and formalwear under the Caruso brand name. The company was founded in 1889 an... [Read more]
Financial Performance
In 2022, LANV's revenue was 422.31 million, an increase of 36.75% compared to the previous year's 308.82 million. Losses were -218.29 million, 234.0% more than in 2021.
Financial numbers in EUR Financial StatementsAnalyst Forecast
According to one analyst, the rating for LANV stock is "Hold" and the 12-month stock price forecast is $5.0.
News
Lanvin Group to Report 2023 Full-Year Audited Results on April 30, 2024
NEW YORK , April 22, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its audited results for the full-year 2023 on Tuesday, April 30, 2024. On ...
Analyses Find Patients With Polycythemia Vera (PV) Treated With BESREMi® (ropeginterferon alfa-2b) Had Increased Probability of Achieving Complete Hematologic Response
BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expert...
Lanvin Group Resiliency was Key in 2023, Preliminary Revenues Up 1% Year-on-Year
Revenue of €426 million for FY2023, a 1% increase over FY 2022 Despite challenging conditions, Lanvin Group grew revenue by 8% in APAC Resiliency through creative transition at Lanvin brand helped imp...
Lanvin Group to Report 2023 Full-Year Preliminary Revenues on February 21, 2024
NEW YORK , Feb. 6, 2024 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its 2023 revenue results conference call. The Group will re...
Lanvin Group Holdings Limited to Hold Annual General Meeting on December 21, 2023
NEW YORK , Dec. 8, 2023 /PRNewswire/ -- Lanvin Group Holdings Limited (NYSE: LANV, the "Company" or "Lanvin Group"), a global luxury fashion group, today announced that it will hold its annual general...
Lanvin Group Announces New CEO
NEW YORK, Dec. 8, 2023 /PRNewswire/ -- The board of Lanvin Group (NYSE: LANV) today announced that Joann Cheng, the group's founding Chairman and Chief Executive Officer, has informed the board that s...
Lanvin Group Posts 6.4% Y-o-Y Revenue Growth In H1 2023
Group's Resilient Business Model Sees Growth Across All Channels and Geographies Group Revenue of €215 million for H1 2023, a 6.4% increase over H1 2022 Group Gross Profit Margin improved to 58.5% and...
Lanvin Group to Report 2023 First-Half Results on August 30, 2023
NEW YORK , Aug. 16, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will release its unaudited results for the first half of 2023 on Wednesday, August 30, 2...
Lanvin Group Posts Record Sales and Continued Margin Improvement in 2022. Revenues Up 37% Year-over-Year.
Revenues of €422 million for FY2022, a 37% increase over FY2021 Margin profile improvement with Group gross profit margin increasing to 56% and both contribution profit(1) and adjusted EBITDA margins ...
Lanvin Group to Report 2022 Full-Year Audited Results on April 20, 2023
NEW YORK , April 10, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, will have its first audited results conference call since its public listing. The Group...
Lanvin's IPO Strengthens The Fall Winter 2023 Collection
Creative Director Bruno Sialelli's latest offering for the 134-year-old houses singled wearable merchandise with a high interest quotient.
Lanvin Group Achieves Record Sales in 2022
P reliminary Revenues Up 38% Year-on-Year Revenues of €425 million for FY2022, a 38% increase on FY 2021, exceeding previous guidance (1) All portfolio brands delivered growth, with flagship brand Lan...
Lanvin Group to Report 2022 Full-Year Preliminary Revenues on February 17, 2023
NEW YORK , Feb. 10, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today opened registration for its first revenue results conference call since its public...
Clinical Review of ropeginterferon alfa-2b Suggests Amended Dosing Schedule May Support Improved Clinical Outcomes in Polycythemia Vera
BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep exper...
Lanvin Group Plans to Announce 2022 Full-Year Preliminary Revenue Results on February 17, 2023; Announces Management Change
NEW YORK , Jan. 31, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today announced that it will report its unaudited full-year 2022 preliminary revenue res...
Lanvin Group Appoints Veteran Entertainment Executive, Ceci Kurzman as a New Independent Director; and Announces Changes in Composition of Board Committees
NEW YORK, Jan. 6, 2023 /PRNewswire/ -- Lanvin Group (NYSE: LANV, the "Group"), a global luxury fashion group, today announced the appointment of Ms. Ceci Kurzman as a new independent director to its B...
Lanvin Group Debuts on NYSE under Ticker "LANV"
NEW YORK , Dec. 15, 2022 /PRNewswire/ -- Lanvin Group (the "Group"), a global luxury fashion group, and Primavera Capital Acquisition Corporation (NYSE: PV) ("PCAC"), today announced the completion o...
New Ropeginterferon alfa-2b Data Show Importance of Proactive Care Earlier in the Polycythemia Vera Patient Journey
BURLINGTON, Mass.--(BUSINESS WIRE)--PharmaEssentia USA Corporation, a subsidiary of PharmaEssentia Corporation (TPEx:6446), a global biopharmaceutical innovator based in Taiwan leveraging deep exper...
Lanvin Group and Primavera Capital Acquisition Corporation Announce Updates in Relation to Business Combination
South Korea's Handsome Corporation will join Lanvin Group's roster of strategic investors Business combination agreement amended to remove closing condition in relation to minimum amount of cash Prima...
Lanvin Group and Primavera Capital Acquisition Corp. Announces Effectiveness of Registration Statement and Extraordinary General Meeting Date for Proposed Business Combination
SHANGHAI , Nov. 4, 2022 /PRNewswire/ -- November 4, 2022 – Lanvin Group (the "Group"), a global luxury fashion group, today announced that, the U.S. Securities and Exchange Commission ("SEC") has decl...